Understanding and Responding to the COVID-19 Pandemic Effect on the Magnitude of Alcohol-Related Liver Disease in Alberta.

了解和应对 COVID-19 大流行对艾伯塔省酒精相关肝病严重程度的影响。

• 批准号: 460228
• 负责人: Shaheen Abdel-Aziz M
• 金额: $ 30.81万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-11-01 至 2023-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=460228&lang=en
• 关键词: Develop Clinical Care Pathway; Evaluate Disease Burden; Primary Care Setting

Approximately 1 in 4 Canadians is practicing high-risk alcohol drinking (more than 10 drinks a week for women and 15 drinks a week for men) based on the Canadian guidelines. There has been a striking increase of alcohol sales and consumption in relation t

根据加拿大指南，大约四分之一的加拿大人正在进行高风险饮酒（女性每周饮酒超过10杯，男性每周饮酒15杯）。与此同时，酒精的销售和消费量急剧增加。